triple metabolic-receptor agonist
CELA-3RT
Starting at $140 per vial
Checking availability…
Description
CELA-3RT (LY3437943) is a synthetic 39-amino-acid peptide analogue of glucose-dependent insulinotropic polypeptide, modified with a C20 fatty-diacid moiety to extend stability in assay conditions. Molecular weight approximately 4731 Da. In vitro, it acts as a triple agonist at glucose-dependent insulinotropic polypeptide, glucagon-like peptide and glucagon receptors, activating class B G-protein-coupled receptor cAMP signalling. Supplied as a lyophilised powder. For laboratory research use only.
For research use only
These statements have not been evaluated by the Food and Drug Administration. Supplied strictly for in-vitro laboratory research. Not for human or veterinary use. Nothing on this site is medical advice or a statement about any health outcome. Individual research outcomes vary.
Lab tested for quality and potency
Every lot is released only after independent third-party testing. Certificates of analysis are available on request.
Purity · Science · Precision · Stability
The same standards on every lot
"Purity, handling and storage decide whether a result is repeatable. Everything else is downstream of how the vial was made and shipped."
Other compounds in the catalog
MOTS-c
mitochondrial-derived peptide
From $65 per vial
NAD+
pyridine dinucleotide coenzyme
From $150 per vial
BPC-157
pentadecapeptide
From $70 per vial
CJC-1295 + Ipamorelin
GHRH analogue + GHS-R1a agonist blend
From $75 per vial
Products shown are research peptides supplied for research use and are not evaluated by the FDA. Nothing here is medical advice.
CELA-3RT
From $140 per vial
- No long-term contracts
- Flat price per vial
- Batch-tested purity
- Tracked delivery
Checking availability…
Recurring orders can be cancelled any time before the next billing date.
Disclaimer
Research peptides are supplied for research use and are not evaluated by the FDA for safety, effectiveness or quality.
Supplied strictly for in-vitro laboratory research. Not for human or veterinary use. Nothing on this site is medical advice or a statement about any health outcome. Individual research outcomes vary.
Supporting studies
- Review of peptide stability and handling in laboratory settings, Journal of Placeholder Chemistry, 2021.
- Analytical verification of synthetic peptide identity, Placeholder Research Reports, 2022.
- Purity and potency profile of research-grade preparations, Journal of Placeholder Analysis, 2020.
- Analytical methods for peptide identity confirmation, Placeholder Research Review, 2023.
- Longitudinal review of lyophilised compound stability, Placeholder Research Annals, 2024.